Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets close in 12 minutes
ALL ORDS
7,959.10
+33.90
(+0.43%)
ASX 200
7,705.40
+29.60
(+0.39%)
AUD/USD
0.6529
-0.0031
(-0.47%)
OIL
82.58
-0.14
(-0.17%)
GOLD
2,163.40
-0.90
(-0.04%)
Bitcoin AUD
100,172.88
-4,411.81
(-4.22%)
FEELING THE PINCH?
Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now
Cellectar Biosciences Inc (NV4.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
3.1200
-0.0800
(-2.50%)
At close: 08:08PM CET
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
25,729
19,220
17,586
10,141
Selling general and administrative
8,107
9,594
6,545
5,150
Total operating expenses
33,835
28,814
24,131
15,290
Operating income or loss
-33,835
-28,814
-24,131
-15,290
Total other income/expenses net
-
-
6.634
185.28
Income before tax
-37,810
-28,661
-24,122
-15,094
Income tax expense
-
-60
0
-
Income from continuing operations
-37,750
-28,601
-24,122
-15,094
Net income
-37,750
-28,601
-24,122
-15,094
Net income available to common shareholders
-37,750
-28,601
-24,122
-15,094
Basic EPS
-3.26
-4.05
-4.35
-7.60
Diluted EPS
-3.26
-4.05
-4.35
-7.60
Basic average shares
10,931
7,056
5,552
1,981
Diluted average shares
10,931
7,056
5,552
1,981
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your privacy choices
About our ads
© 2024 Yahoo. All rights reserved.